Physician profile
Hillary Clair Morris
NPI 1790971356
$8,537.19
in general payments reported to CMS, 2019-2025
42 companies · $1,387 in 2025
The $1,387 reported for 2025 was more than what 91% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,287 · 2022: $1,610 · 2023: $1,464 · 2024: $1,788 · 2025: $1,387.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,540 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,539.68 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $1,035.00 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $1,015.43 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $919.28 | 2021-2025 | Jardiance, Tradjenta, Synjardy |
| Pfizer INC. | $852.84 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $684.63 | 2021-2025 | Airsupra, Breztri, Farxiga |
| Abbvie INC. | $663.51 | 2021-2025 | |
| Glaxosmithkline, LLC. | $338.08 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Amgen INC. | $273.46 | 2021-2025 | Otezla, Repatha, Otezla |
| Novartis Pharmaceuticals Corporation | $219.21 | 2021-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $204.99 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $197.79 | 2021-2023 | |
| Astellas Pharma US INC | $186.89 | 2022-2025 | Veozah, Myrbetriq |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $168.32 | 2021-2025 | Xifaxan |
| Esperion Therapeutics, INC. | $162.61 | 2021-2023 | Nexletol |
| Janssen Pharmaceuticals, INC | $153.57 | 2021-2023 | Xarelto |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $137.04 | 2024 | Insignia |
| Takeda Pharmaceuticals U.S.A., INC. | $135.35 | 2021-2025 | Trintellix |
| Kowa Pharmaceuticals America, INC. | $121.82 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $117.87 | 2021 | |
| Dexcom, INC. | $108.05 | 2023-2025 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $94.27 | 2023-2025 | Cologuard Collection Kit |
| Amarin Pharma, INC. | $89.66 | 2021 | |
| Abbott Laboratories | $79.64 | 2021-2024 | Freestyle Libre 3 |
| Biogen, INC. | $70.20 | 2021 | |
| Corcept Therapeutics | $56.04 | 2025 | Korlym |
| Idorsia Pharmaceuticals US INC | $55.68 | 2022-2023 | Quviviq |
| Merck Sharp & Dohme LLC | $54.65 | 2022-2025 | Capvaxive |
| Otsuka America Pharmaceutical, INC. | $50.79 | 2024 | Rexulti |
| Mylan Specialty L.P. | $48.33 | 2024 | Yupelri |
| Eisai INC. | $33.40 | 2021 | |
| Seqirus USA INC | $24.76 | 2025 | Fluad, Flucelvax |
| Corium, LLC | $23.86 | 2023 | Azstarys |
| Boston Scientific Corporation | $21.10 | 2025 | Watchman Flx |
| Phathom Pharmaceuticals, INC. | $19.89 | 2024 | Voquezna |
| Xeris Pharmaceuticals, INC. | $17.91 | 2025 | Gvoke Hypopen |
| Tactile Systems Technology INC | $17.57 | 2024 | Flexitouch Plus, Entre Plus |
| Almatica Pharma LLC | $17.39 | 2021 | |
| Inspire Medical Systems, INC. | $14.65 | 2025 | Inspire |
| Biodelivery Sciences International, INC. | $13.42 | 2021 | |
| Jazz Pharmaceuticals INC. | $12.97 | 2021 | |
| Tolmar, INC. | $12.83 | 2023 | |
| Currax Pharmaceuticals LLC | $12.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hillary Morris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.